Apixaban

Details

Files

Generic Name:

Apixaban

Project Status:

Complete

Therapeutic Area:

Venous thromboembolic events, treatment and prevention of recurrence

Manufacturer:

Bristol-Myers Squibb Canada and Pfizer Canada Inc. Alliance

Call for patient/clinician input open:

August 20, 2014

Brand Name:

Eliquis

Project Line:

Reimbursement Review

Project Number:

SR0397-000

Call for patient/clinician input closed:

October 9, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

Not achieved

Submission Type:

Initial

Indications:

Thromboembolic events (venous), treatment and prevention of recurrence

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

May 7, 2015

Last Updated : September 18, 2014